Therapeutics Today

TT Index

2024

September

• Recent NMIC Bulletin
• Guidance and Advice
• Regular features
• Signposting

August

• Recent NMIC Bulletins
• Guidance and Advice
• Regular features
• Signposting

 

July

• Guidance and Advice
• HSE Antibiotic Prescribing
• Medication Safety Minutes
• Communicable Diseases
• Signposting

 

June

• Guidance and Advice
• Antibiotic Prescribing
• Medication Safety
• Regulatory Information
• Communicable Diseases
• SignPosting

May

• • Risk of adverse events following the initiation of antihypertensives in older people with complex health needs
  • New NMIC learning module on HSeLanD
  • Age-related risk of serious fall events and opioid Analgesic Use
  • Use of progestogens and the risk of intracranial meningioma
• April
  • Practical prescribing: proton pump inhibitors (PPIs)
  • Results of NMIC survey 2024
  • Prevalence of potentially medications among newly treated patients with type 2 diabetes mellitus (T2DM)
  • Learning to swallow pills?
  • Health Products Regulatory Authority (HPRA) update
• March
  • Practical prescribing - thiazides diuretics
  • Correct storage of biological disease-modifying  anti-rheumatic drugs at home
  • Drug-induced dermatomyositis
  • Potentially inappropriate prescribing and potential prescribing omissions and their association with adverse drug reaction-related hospital admission
• February
  • Gabapentinoids in Ireland 2010 to 2020
  • Medicine shortages
  • NMIC publications survey 2024
  • Crushed tablet administration for patients with dysphagia or enteral feeding
• January
  • Help shape our publications, your opinion counts – please take the NMIC Survey 2024
  • Drug-drug interactions and risk of adverse drug reaction-related hospital admissions in the older population
  • Emollients – comparison of lotions, creams, gels and ointment for childhood eczema
  • Safety outcomes when switching between biosimilar and reference biological medicines

2023

• December
  
  • Sharing prescription medications
  • "Weekend warrior” physical activity & incident cardiovascular disease
  • Breastfeeding & the incidence of infant illness in Ireland
  • Primary prevention of CVD of Mediterranean diet in women

• November
  • Risk of Gastrointestinal Adverse Events Associated with GLP-1 Receptor Agonists for Weight Loss
  • Paediatric ADHD medication errors reported to US poison Centres
  • Managing drugs with anticholinergic activity

• October

  • Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs.
  • Prevalence and predictors of primary non-adherence in primary care
  • Aspirin for secondary prevention of cardiovascular disease

• September

  • Folic acid supplementation to prevent neural tube defects
  • Association between daily step count and all-cause and cardiovascular mortality
  • Cardiac and renal effects of sodium-glucose co-transporter 2 (SGLT2)
• August
  
  • Electrolyte disturbances due to proton pump inhibitors (PPIs)
  • Vaccine hesitancy
  • Familial hypercholesterolaemia (FH)
• July
  
  • COPD exacerbations and pneumonia hospitalisations among new users of combination maintenance inhalers.
  • Health Products Regulatory Authority updates
  • Polypharmacy and cumulative anticholinergic burden in older adults hospitalised with a fall
  • Low-dose aspirin and risk of serious falls and fractures in healthy older people
• June
  
  • Bipolar disorder – monitoring drug interventions
  • Trends in severe outcomes of adults and patients hospitalised with COVID -19
  • Women’s pre-conception health in England
• May
  
  • Medication work among nonagenarians
  • Use of pharmacy services in community-dwelling middle-age and older adults.
  • NMIC useful medicines information resources webpage
  • Oral anticoagulant safety audit
  • Prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN).
• April
  
  • Breast cancer risk and contraception
  • NMIC CPD module on HSeLanD!
  • Prevention of hospital admissions for adverse drug reactions
  • Withdrawing from SSRI antidepressants
• March
  
  • BRAINS & AIMS
  • Further NMIC learning module on HSeLanD!
  • Reduce unnecessary use of proton pump inhibitors (PPIs)
  • Teachable moment – Paxlovid   avoiding drug-drug interactions
  • Guideline updates
• February
  • Metabolic adverse events associated with systemic corticosteroid therapy
  • Prevalence of drug-drug interactions in older adults in the community
  • Values and preferences of patients and caregivers regarding eczema treatment
  • Online eczema interventions to support self-care for children and young people
  • Updated National Clinical Guidelines in Obstetrics and Gynaecology

• January
  • Adverse drug reactions in older people in the community in Ireland
  • Thinking of a New Year’s resolution
  • Gynaecomastia
  • Glucocorticoid induced adrenal insufficiency (GC-AL)
  • Regular Updates
  • New Feature

2022

• December
  
  • Thank you very much!
  • Morning versus evening antihypertensive medicine
  • Health Products Authority (HPRA) Update
  • Switching from a metered dose inhaler to a dry powder inhaler – effects on climate emissions and asthma control
  • Effectiveness of physical activity interventions delivered or prompted by healthcare professionals in primary care
  • NMIC Therapeutics Today 2022
• November
  
  • The revised isotretinoin pregnancy prevention programme: awareness, knowledge & implementation in practice of healthcare professionals.
  • Risk of co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants.
  • Medicines Management Programme updates.
  • Effectiveness of preconception care interventions in primary care.
  • Paxlovid: update on prescribing and access
• October
  
  • ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.
  • HSE-Medicines Management Programme Update
  • Trends in direct oral anticoagulant prescribing in primary care in England
  • Gastrointestinal bleeding risk after concomitant treatment with non-vitamin K oral anticoagulants and oral glucocorticoids.
• September
  • Obesity and oral emergency contraception
  • Recent journal Articles on pregnancy
  • Prescribing trends of antihypertensive medicines in the UK over 31 years
  • Health Products Regulatory Authority updates
  • HSeLanD Learning Module
• August
  
  • Adverse drug reactions, multimorbidity and polypharmacy
  • Information resources for Ukrainian medicines
  • NMIC useful information resources webpage update
  • Medication Safety Minutes
  • Guideline update
• July Supplement
  
  • Paxlovid : Update on prescribing and access
  • Key safety Points
  • Eligibility and prescribing considerations
  • Drug-drug interactions
  • Supply
• July
  
  • Opioids versus non-opioids following surgical discharge
  • Further NMIC learning module on HSeLanD
  • Management of Gout
  • Guidance documents update
• June
  
  • Serotonin Syndrome
  • Intramuscular injections in patients taking anticoagulant
  • Guideline updates
  • Drug reaction with eosinophilia and systemic symptoms (DRESS)
  • Use of medications that may raise blood pressure
• May
  
  • Long-term nitrofurantoin therapy
  • Health Products Regulatory Authority updates
  • Guideline updates
  • Montelukast and neuropsychiatric reactions
  • Dose of paracetamol and low body weight
  • Factors to consider when using medicines following bariatric surgery
• April
  
  • Sodium valproate (Epilim) utilisations trends in Ireland
  • Emollients and risk of burns
  • Non- vitamin K antagonist oral anticoagulants (NOACs) and pharmacokinetic drug interactions
  • Examples of medicines that should be prescribed by brand name
  • Guideline updates
  • NMIC CPD modules on contraception
  • Ukrainian Medicines Information Resources
• March
  • Paxlovid and risk of drug interactions
  • Ireland’s second One Health National Action Plan (iNAP2) on Antimicrobial Resistance 2021-2025
  • Regular Updates
  • Measles
• February
  
  • Overactive bladder (OAB) in women
  • Regular updates
  • Patient adherence, satisfaction and knowledge of direct oral anticoagulants (DOACs)
  • Impact of Gp-delivered medication review of older patients with multimorbidity and polypharmacy

• January
  
  • Associations of Statins adherence and lipid targets with adverse outcomes in patients following myocardial infarction
  • Fatal adverse drug reactions
  • Childhood constipation